How Smaller, Explainable AI Outperforms Large Models in Clinical Trials
You’ve built a company on the premise that smaller, specialized architectures outperform large models in clinical settings. What does the data show that convinced you to go against the prevailing direction of the field? I’ve been fortunate to learn from some extraordinary computational scientists across both medicine and artificial intelligence. After completing my doctorate at…
